Asia Pacific Platelet Rich Plasma Market at a CAGR of 15.4% Between 2015 and 2023

By , in PR PR Sports on .

Albany, NY — 02/14/2018 — Themarket for platelet rich plasmain Asia Pacific features a semi-consolidated competitive landscape. A new study by Transparency Market Research (TMR) indicates that players such as Arthrex Inc., Harvest Technologies, DePuy Synthes, Zimmer-Biomet, and Stryker have a strong foothold in the market owing to their strong expertise and extensive research and development efforts. By the end of 2023, the overall value of the Asia Pacific platelet rich plasma (PRP) market is estimated to rise to US$110.0 mn. The market will expand at a noteworthy 15.4% CAGR from 2015 to 2023.

Demand for Platelet Rich Plasma to Remain High for Orthopedic Surgeries

Based on application, the orthopedic surgeries segment will continue to dominate the market until 2023. The widening base of geriatrics is one of the primary factors fuelling the growth of the segment. The demand for PRP in cosmetic surgeries is also anticipated to increase at a brisk pace during the review period. In terms of country, China will continue to account for the lion’s share in the region until 2023. The growth of the country can be attributed to the high awareness and growing investments in research and development activities in the field of PRP. Owing to these factors, the country will rise at a remarkable CAGR of 17.0% during the same period.

Get Brochure of Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8707

Advent of Advanced PRP Devices to Allow Asia Pacific Market to Gain Traction

The continual research and development activities have led to the introduction of several advanced and innovative PRP devices, which in turn has provided a fillip to the Asia Pacific PRP market. Over the past few years, Asia Pacific has witnessed a boom in the medical tourism sector. Advancements in healthcare in the region have rendered it as a major destination for cosmetic surgeries at affordable costs for people from all across the world. “With millions of people opting for cosmetic surgeries, especially non-invasive type, the demand for PRP in APAC is expected to follow a notable growth trajectory,� says TMR’s lead analyst.

Besides this, the growing incidence of sports injuries, orthopedic diseases, obesity, neurological disorders, and cardiovascular diseases is stoking the growth of the market. The increasing awareness regarding PRP devices across developing countries is also playing a vital role in the development of the Asia Pacific platelet rich plasma market.

Get Sample Copy of the Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8707

Increasing Prices Due to Commercialization of Cosmetic Surgeries to Hamper Growth Prospects

“In recent type, cosmetic surgeries have picked up momentum as a commercialized procedure rather than a treatment for certain skin issues,� says a TMR analyst. The commercialization of these surgeries has triggered the prices of PRP therapies. This, in turn, is acting as a stumbling block in the growth of the Asia Pacific platelet rich plasma market. Moreover, the rising awareness pertaining to the threats associated with the use of PRP is limiting its widespread adoption across the region. Nevertheless, with the introduction of new applications of PRP technologies, the market is expected to tread along a healthy growth track in the near future.

Get Discount on Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=8707

The review is based on information published by Transparency Market Research in a report, titled “Platelet Rich Plasma Market (Type – Pure Platelet-Rich Plasma (P-PRP), Leukocyte-Rich Platelet-Rich Plasma (L-PRP), and Pure Platelet-Rich Fibrin (P-PRF)/ Leukocyte-Rich Platelet-Rich Fibrin (L-PRF); Origin – Autologous Platelet-Rich Plasma, Allogeneic Platelet-Rich Plasma, and Homologous Platelet-Rich Plasma; Application – Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery, and Urology, Cardiothoracic, Oral and Maxillofacial, and Periodontal) – Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023.â€�

The following two tabs change content below.
Bob Allen

Bob Allen

Bob Allen is The Daily Telescope''s senior editor. He is also a nationally syndicated newspaper columnist and a bestselling author. He lives in Los Angeles and covers the intersection of money, politics and finance. He appears periodically on national television shows and has been published in (among others) The National Post, Politico, The Atlantic, Harper’s, Wired.com, Vice and Salon.com. He also has served as a journalist and consultant on documentaries for NPR and ShowTime. In 2014, he was the winner of the Society of American Business Editors and Writers' investigative journalism award, and the winner of the Izzy Award for Journalism from Ithaca College's Park Center for Independent Media. He was also a finalist for UCLA's Gerald R. Loeb Award and Syracuse University's Mirror Award. Before becoming a journalist in 2006, Sirota worked in Washington for, among others, U.S. Rep. Bernie Sanders, the U.S. House Appropriations Committee Minority Staff and the Center for American Progress.
%d bloggers like this: